The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.
about
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial.Who benefited most from higher cumulative dose of cisplatin among patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiation therapy? A retrospective study of 527 cases.A comparison of weekly versus 3-weekly cisplatin during concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma using intensity modulated radiation therapy: a matched study.Accuracy of a Staging System for Prognosis of 5-Year Survival of Patients With Nasopharyngeal Carcinoma Who Underwent Chemoradiotherapy.Cycle number of neoadjuvant chemotherapy might influence survival of patients with T1-4N2-3M0 nasopharyngeal carcinoma.
P2860
The Cumulative Cisplatin Dose Affects the Long-Term Survival Outcomes of Patients with Nasopharyngeal Carcinoma Receiving Concurrent Chemoradiotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@ast
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@en
type
label
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@ast
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@en
prefLabel
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@ast
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@en
P2093
P2860
P356
P1433
P1476
The Cumulative Cisplatin Dose ...... Concurrent Chemoradiotherapy.
@en
P2093
Ai-Hua Lin
Li-Zhi Liu
Wen-Fei Li
Yan-Ping Mao
P2860
P2888
P356
10.1038/SREP24332
P407
P577
2016-04-13T00:00:00Z
P5875
P6179
1029413405